Clinical studyEffect of heparin-induced free fatty acid elevation on myocardial oxygen consumption in man☆
References (54)
- et al.
Oxygen consumption of the heart. Newer concepts of its multifactoral determination
Am J Cardiol
(1968) - et al.
Increased plasma-free-fatty acid concentrations and their significance in patients with acute myocardial infarction
Lancet
(1969) - et al.
Serum free-fatty acids after acute myocardial infarction and cerebral vascular occlusion
Lancet
(1966) - et al.
Serum free-fatty acids and their relation to complications after acute myocardial infarction
Lancet
(1969) - et al.
Initial metabolic and hormonal response to acute myocardial infarction
Lancet
(1974) - et al.
Heparin and human lipid metabolism
Lancet
(1969) - et al.
The determination of gases in blood and other solutions by vacuum extraction and manometric measurement
J Biol Chem.
(1924) - et al.
Colorimetric determination of free fatty acids in biological fluids
J Lipid Res
(1965) Lipid metabolism of the heart and arteries in relation to ischaemic heart disease
Lancet
(1973)- et al.
Effect of palmitate on hypoxic cardiac performance
J Mol Cell Cardiol
(1975)
Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction
Lancet
(1968)
Binding of long-chain fatty acids to bovine serum albumin
J Lipid Res
(1969)
The effect of a high molar FFA/albumin ratio in the perfusion medium on rhythm and contractility of the isolated rat heart
J Mol Cell Cardiol
(1973)
Inhibition of enzyme activities by free fatty acids
J Biol Chem
(1968)
Uncoupling activity of long-chain fatty acids
Biochim Biophys Acta
(1962)
Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction
Am J Cardiol
(1975)
Effect of heparin in anticoagulant doses on the electrocardiogram and cardiac enzymes in patients with acute myocardial infarction
Am J Cardiol
(1976)
Effect of a nicotinic-acid analogue on raised plasma-free-fatty-acids after acute myocardial infarction
Lancet
(1973)
Reduction of hospital mortality of acute myocardial infarction with glucose-insulin-potassium infusion
Am Heart J
(1976)
Effect of free fatty acid on the oxygen consumption of perfused rat heart
Am J Physiol
(1966)
Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs
J Clin Invest
(1971)
Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction
Br Med J
(1969)
Plasma free fatty acid and catecholamine levels in patients with acute myocardial infarction
Br Heart J
(1971)
Anticoagulant therapy of coronary thrombosis with myocardial infarction
JAMA
(1948)
Limited use of anticoagulants in acute myocardial infarction: analysis of 1000 “good risk” cases
JAMA
(1957)
Clearing factor, a heparin-activated lipoprotein lipase
J Biol Chem
(1955)
Cited by (21)
Characterization of a highly effective preparation for suppression of myocardial glucose utilization
2020, Journal of Nuclear CardiologyAngiogenesis and low molecular weight heparin
1994, Journal of the American College of CardiologyCardiac metabolic effects of heparin differentiate between patients with normal and stenotic coronary arteries
1990, International Journal of CardiologyEarly detection of myocardial ischemia by myocardial free fatty acid extraction in patients with exercise-induced angina pectoris
1989, The American Journal of CardiologyMyocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease
1988, The American Journal of CardiologyThe effects of acute hypertriglyceridemia and high levels of free fatty acids on left ventricular function
1985, American Heart Journal
- ☆
This research was supported in part by the Specialized Center of Research for Ischemic Heart Disease, Contract 1P17HL 17667-02, the Cardiovascular Research and Training Center, Program Project Grant HL 11,310 (Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute), National Institutes of Health Grant T01LM00154, Clinical Research Unit Grant M01-RR00032-13 (General Clinical Research Centers Program, Division of Research Resources), National Institutes of Health, Bethesda, Maryland and Project 5566-01 of the Veterans Administration, Washington, D. C.
Copyright © 1977 Published by Elsevier Inc.